IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness. (7th November 2013)

Record Type:: Journal Article
Title:: IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness. (7th November 2013)
Main Title:: IL-12 primed CD8+ T-cells possess enhanced persistence and anti-tumor efficacy because of greater IL-7 responsiveness
Authors:: Johnson, C Bryce
May, Bennett R
Cloud, Colleen A
Rubinstein, Mark P
Cole, David J
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 1(2013)Supplement 1
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 1(2013)Supplement 1
Issue Display:: Volume 1, Issue 1 (2013)
Year:: 2013
Volume:: 1
Issue:: 1
Issue Sort Value:: 2013-0001-0001-0000
Page Start:
Page End:
Publication Date:: 2013-11-07
Subjects:: Irradiate Mouse -- Effector Phase -- Great Expansion -- Molecule STAT5 -- Adoptive Cell Transfer
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1186/2051-1426-1-S1-P17 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19215.xml